NCT00625651 Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00614393 Study of Dalotuzumab (MK-0646) in Combination With Cetuximab and Irinotecan in Metastatic Colorectal Cancer (MK-0646-004) Status COMPLETED Phase PHASE2
NCT00598156 Chemotherapy and Avastin Followed by Maintenance Treatment With Avastin +/- Tarceva Status COMPLETED Phase PHASE3
NCT00574171 Phase II Trial of Lapatinib & Capecitabine for Patients With Refractory Advanced Colorectal Adenocarcinoma Status COMPLETED Phase PHASE2
NCT00563316 Effect of Panitumumab on the Pharmacokinetics of Irinotecan Status COMPLETED Phase PHASE1
NCT00558051 Alpha-type-1 Dendritic Cell-based Vaccines in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1
NCT00531115 Phase II Study to Evaluate Safety and Efficacy of Cetuximab in Combination With XELOX for 12 Weeks Followed by Maintenance Treatment With Cetuximab Plus Capecitabine as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer. Status TERMINATED Phase PHASE2
NCT00508404 Panitumumab Plus FOLFIRI in First-line Treatment of Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00494221 A Phase I/II Study of Cediranib (AZD2171) in Japanese Metastatic Colorectal Cancer Patients in Combination With FOLFOX Status COMPLETED Phase PHASE1/PHASE2
NCT00489697 Evaluation of Contrast-enhanced Ultrasound Imaging for the Early Estimate of Bevacizumab Effect on Colorectal Cancer Liver Metastases Status COMPLETED Phase NA
NCT00475293 Panitumumab in Combination With Irinotecan Chemotherapy as 2nd-line Therapy in Subjects With mCRC Status COMPLETED Phase PHASE2
NCT00459901 Study of the Antitumor Activity of Capecitabine in Combination With Erlotinib in Patients With Metastatic Colorectal Cancer Status TERMINATED Phase PHASE2
NCT00457691 Study Of FOLFIRI Chemotherapy With Or Without Sunitinib In Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE3
NCT00444041 Pre- and Postoperative Chemotherapy Including Bevacizumab in Potentially Curable Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00435097 Computer Assisted Early Detection of Liver Metastases From fMRI Maps Status UNKNOWN Phase N/A
NCT00422773 Safety of Cetuximab and Oxaliplatin/5-FU/FA/Irinotecan in First-Line Treatment of Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00418938 SPIRITT - Second-Line Panitumumab Irinotecan Treatment Trial Status COMPLETED Phase PHASE2
NCT00414492 Pattern of Cell Death Following Neoadjuvant Therapy for Metastatic Colon Cancer Status COMPLETED Phase N/A
NCT00411450 Panitumumab Regimen Evaluation in Colorectal Cancer to Estimate Primary Response to Treatment Status COMPLETED Phase PHASE2